Skip Nav Destination
Issues
Clinical Care/Education/Nutrition
Circulating 1,5-Anhydroglucitol Levels in Adult Patients With Diabetes Reflect Longitudinal Changes of Glycemia: A U.S. trial of the GlycoMark assay
Janet B. McGill, MD; Thomas G. Cole, PHD; William Nowatzke, PHD; Shannon Houghton, MD; Erika B. Ammirati, BS; Theresa Gautille, RN; Mark J. Sarno, BA
Diabetes Care August 2004, Vol.27, 1859-1865. doi:https://doi.org/10.2337/diacare.27.8.1859
Improved Plasma Glucose Control, Whole-Body Glucose Utilization, and Lipid Profile on a Low-Glycemic Index Diet in Type 2 Diabetic Men: A randomized controlled trial
Salwa W. Rizkalla, MD, PHD; Laika Taghrid, MD; Muriel Laromiguiere, PHARMD, PHD; Dorothée Huet, MD; Josette Boillot, PHD; Aude Rigoir, RN; Fabienne Elgrably, MD; Gerard Slama, MD
Diabetes Care August 2004, Vol.27, 1866-1872. doi:https://doi.org/10.2337/diacare.27.8.1866
Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart
Guillermo E. Umpierrez, MD, FACP, FACE; Ruben Cuervo, MD; Ana Karabell, MD; Kashif Latif, MD; Amado X. Freire, MD, MPH; Abbas E. Kitabchi, PHD, MD
Diabetes Care August 2004, Vol.27, 1873-1878. doi:https://doi.org/10.2337/diacare.27.8.1873
Epidemiology/Health Services/Psychosocial Research
The Incidence of Congestive Heart Failure in Type 2 Diabetes: An update
Gregory A. Nichols, PHD; Christina M. Gullion, PHD; Carol E. Koro, PHD; Sara A. Ephross, PHD; Jonathan B. Brown, PHD, MPP
Diabetes Care August 2004, Vol.27, 1879-1884. doi:https://doi.org/10.2337/diacare.27.8.1879
Incidence of Lower-Extremity Amputation in American Indians: The Strong Heart Study
Helaine E. Resnick, PHD, MPH; Elizabeth A. Carter, MPH; Jay M. Sosenko, MD, MS; Susan J. Henly, PHD, RN; Richard R. Fabsitz, PHD; Frederick K. Ness, MD; Thomas K. Welty, MD; Elisa T. Lee, PHD; Barbara V. Howard, PHD
Diabetes Care August 2004, Vol.27, 1885-1891. doi:https://doi.org/10.2337/diacare.27.8.1885
Are We Underestimating Diabetes-Related Lower-Extremity Amputation Rates?: Results and benefits of the first prospective study
Gerry Rayman, MD, FRCP; Singhan T.M. Krishnan, MRCP; Neil R. Baker, BSC, DPM; Alison M. Wareham, BSC; Anne Rayman, RN
Diabetes Care August 2004, Vol.27, 1892-1896. doi:https://doi.org/10.2337/diacare.27.8.1892
Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease
Andrew J. Palmer, BSC, MBBS; Lieven Annemans, PHD; Stéphane Roze, MS; Mark Lamotte, MD; Pablo Lapuerta, MD; Roland Chen, MD; Sylvie Gabriel, MD; Paulo Carita, PHD; Roger A. Rodby, MD; Dick de Zeeuw, MD, PHD; Hans-Henrik Parving, MD
Diabetes Care August 2004, Vol.27, 1897-1903. doi:https://doi.org/10.2337/diacare.27.8.1897
Excess Hospitalizations, Hospital Days, and Inpatient Costs Among People With Diabetes in Andalusia, Spain
Gabriel Olveira-Fuster, MD; Pilar Olvera-Márquez, MD; Florentino Carral-Sanlaureano, MD; Stella González-Romero, MD; Manuel Aguilar-Diosdado, MD; Federico Soriguer-Escofet, MD
Diabetes Care August 2004, Vol.27, 1904-1909. doi:https://doi.org/10.2337/diacare.27.8.1904
Emerging Treatments and Technologies
Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes
Diabetes Care August 2004, Vol.27, 1910-1914. doi:https://doi.org/10.2337/diacare.27.8.1910
Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors: Continuous glucose–error grid analysis illustrated by TheraSense Freestyle Navigator data
Diabetes Care August 2004, Vol.27, 1922-1928. doi:https://doi.org/10.2337/diacare.27.8.1922
Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease
Martin Magnusson, MD; Olle Melander, MD, PHD; Bo Israelsson, MD, PHD; Anders Grubb, MD, PHD; Leif Groop, MD, PHD; Stefan Jovinge, MD, PHD
Diabetes Care August 2004, Vol.27, 1929-1935. doi:https://doi.org/10.2337/diacare.27.8.1929
Pathophysiology/Complications
Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA1c Levels at Onset
Shoichiro Tanaka, MD; Toyoshi Endo, MD, PHD; Kaoru Aida, MD, PHD; Hiroki Shimura, MD, PHD; Norihiko Yokomori, MD, PHD; Masahiro Kaneshige, MD, PHD; Fumihiko Furuya, MD, PHD; Shin Amemiya, MD, PHD; Mie Mochizuki, MD, PHD; Koji Nakanishi, MD, PHD; Tetsuro Kobayashi, MD, PHD
Diabetes Care August 2004, Vol.27, 1936-1941. doi:https://doi.org/10.2337/diacare.27.8.1936
Reduced Forearm Blood Flow in Children and Adolescents With Type 1 Diabetes (Measured by Near-Infrared Spectroscopy)
Gerhard Pichler, MD; Berndt Urlesberger, MD; Paul Jirak, MD; Heinz Zotter, MD; Elke Reiterer, MD; Wilhelm Müller, MD; Martin Borkenstein, MD
Diabetes Care August 2004, Vol.27, 1942-1946. doi:https://doi.org/10.2337/diacare.27.8.1942
Female Children and Adolescents With Type 1 Diabetes Have More Pronounced Early Echocardiographic Signs of Diabetic Cardiomyopathy
Bert E. Suys, MD; Nienke Katier, MD; Raoul P.A. Rooman, MD; Dirk Matthys, MD, PHD; Lieve Op De Beeck, ENG; Mark V.L. Du Caju, MD, PHD; Daniel De Wolf, MD, PHD
Diabetes Care August 2004, Vol.27, 1947-1953. doi:https://doi.org/10.2337/diacare.27.8.1947
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study
Frans J.Th. Wackers, MD; Lawrence H. Young, MD; Silvio E. Inzucchi, MD; Deborah A. Chyun, PHD; Janice A. Davey, MSN; Eugene J. Barrett, MD; Raymond Taillefer, MD; Steven D. Wittlin, MD; Gary V. Heller, MD; Neil Filipchuk, MD; Samuel Engel, MD; Robert E. Ratner, MD; Ami E. Iskandrian, MD; for the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators
Diabetes Care August 2004, Vol.27, 1954-1961. doi:https://doi.org/10.2337/diacare.27.8.1954
Association of Carotid Intima-Media Thickness and Arterial Stiffness With Diabetic Retinopathy: The Chennai Urban Rural Epidemiology Study (CURES-2)
Mohan Rema, MBBS, DO, PHD, FABMS; Viswanathan Mohan, MD, MRCP, PHD, DSC, FNASC; Raj Deepa, MPHIL, PHD; Radhakrishnan Ravikumar, DMRD, DMRE, DNB
Diabetes Care August 2004, Vol.27, 1962-1967. doi:https://doi.org/10.2337/diacare.27.8.1962
Does the Aspartic Acid to Asparagine Substitution at Position 76 in the Pancreas Duodenum Homeobox Gene (PDX1) Cause Late-Onset Type 2 Diabetes?
Diabetes Care August 2004, Vol.27, 1968-1973. doi:https://doi.org/10.2337/diacare.27.8.1968
Intraepidermal Nerve Fibers Are Indicators of Small-Fiber Neuropathy in Both Diabetic and Nondiabetic Patients
Gary L. Pittenger, PHD; Madhumita Ray, MS; Niculina I. Burcus, MS; Patricia McNulty, MD; Baher Basta, MD; Aaron I. Vinik, MD, PHD
Diabetes Care August 2004, Vol.27, 1974-1979. doi:https://doi.org/10.2337/diacare.27.8.1974
Variability in Activity May Precede Diabetic Foot Ulceration
David G. Armstrong, DPM, MSC, PHD; Lawrence A. Lavery, DPM, MPH; Katherine Holtz-Neiderer, DPM; Martha J. Mohler, MPH, PHD; Christopher S. Wendel, MS; Brent P. Nixon, DPM, MBA; Andrew J.M. Boulton, MD
Diabetes Care August 2004, Vol.27, 1980-1984. doi:https://doi.org/10.2337/diacare.27.8.1980
Male Sex Increases the Risk of Autoimmunity but not Type 1 Diabetes
Jeffrey P. Krischer, PHD; David D. Cuthbertson, MS; Carla Greenbaum, MD; the Diabetes Prevention Trial-Type 1 Study Group
Diabetes Care August 2004, Vol.27, 1985-1990. doi:https://doi.org/10.2337/diacare.27.8.1985
Non-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes
Rui Jiang, MD, DRPH; Matthias B. Schulze, PHD; Tricia Li, MD; Nader Rifai, PHD; Meir J. Stampfer, MD, DRPH; Eric B. Rimm, SCD; Frank B. Hu, MD, PHD
Diabetes Care August 2004, Vol.27, 1991-1997. doi:https://doi.org/10.2337/diacare.27.8.1991
Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance
Diabetes Care August 2004, Vol.27, 1998-2002. doi:https://doi.org/10.2337/diacare.27.8.1998
Phenotype-Genotype Correlations in a Series of Wolfram Syndrome Families
Casey J.A. Smith, BSC; Patricia A. Crock, MD; Bruce R. King, MD; Cliff J. Meldrum, PHD; Rodney J. Scott, PHD
Diabetes Care August 2004, Vol.27, 2003-2009. doi:https://doi.org/10.2337/diacare.27.8.2003
Adiponectin and Leptin Concentrations May Aid in Discriminating Disease Forms in Children and Adolescents With Type 1 and Type 2 Diabetes
Alba Morales, MD; Clive Wasserfall, MS; Todd Brusko, BS; Carolyn Carter, MD; Desmond Schatz, MD; Janet Silverstein, MD; Tamir Ellis, PHD; Mark Atkinson, PHD
Diabetes Care August 2004, Vol.27, 2010-2014. doi:https://doi.org/10.2337/diacare.27.8.2010
The +276 G/T Single Nucleotide Polymorphism of the Adiponectin Gene Is Associated With Coronary Artery Disease in Type 2 Diabetic Patients
Simonetta Bacci, MD; Claudia Menzaghi, PHD; Tonino Ercolino, MD; Xiaowei Ma, MD; Anna Rauseo, MD; Lucia Salvemini, BSC; Carlo Vigna, MD; Raffaele Fanelli, MD; Umberto Di Mario, MD; Alessandro Doria, MD, PHD; Vincenzo Trischitta, MD
Diabetes Care August 2004, Vol.27, 2015-2020. doi:https://doi.org/10.2337/diacare.27.8.2015
Aldose Reductase Gene Polymorphisms and Peripheral Nerve Function in Patients With Type 2 Diabetes
Katariina Sivenius, MD; Jussi Pihlajamäki, MD; Juhani Partanen, MD; Leo Niskanen, MD; Markku Laakso, MD; Matti Uusitupa, MD
Diabetes Care August 2004, Vol.27, 2021-2026. doi:https://doi.org/10.2337/diacare.27.8.2021
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes
Prevalence and Factor Analysis of Metabolic Syndrome in an Urban Korean Population
Diabetes Care August 2004, Vol.27, 2027-2032. doi:https://doi.org/10.2337/diacare.27.8.2027
Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects
Adamandia D. Kriketos, PHD; Jerry R. Greenfield, FRACP; Phil W. Peake, PHD; Stuart M. Furler, PHD; Gareth S. Denyer, PHD; John A. Charlesworth, FRACP; Lesley V. Campbell, FRACP
Diabetes Care August 2004, Vol.27, 2033-2040. doi:https://doi.org/10.2337/diacare.27.8.2033
Sagittal Abdominal Diameter Is a Strong Anthropometric Marker of Insulin Resistance and Hyperproinsulinemia in Obese Men
Ulf Risérus, MMED, PHD; Johan Ärnlöv, MD, PHD; Kerstin Brismar, MD, PHD; Björn Zethelius, MD, PHD; Lars Berglund, BSC; Bengt Vessby, MD, PHD
Diabetes Care August 2004, Vol.27, 2041-2046. doi:https://doi.org/10.2337/diacare.27.8.2041
Brief Reports
Caffeine Impairs Glucose Metabolism in Type 2 Diabetes
Diabetes Care August 2004, Vol.27, 2047-2048. doi:https://doi.org/10.2337/diacare.27.8.2047
Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes: Effect of 1 year’s cardiovascular risk reduction therapy
Diabetes Care August 2004, Vol.27, 2049-2051. doi:https://doi.org/10.2337/diacare.27.8.2049
Pancreatic Elastase-1 in Stools, a Marker of Exocrine Pancreas Function, Correlates With Both Residual β-Cell Secretion and Metabolic Control in Type 1 Diabetic Subjects
Franco Cavalot, MD; Katia Bonomo, MD; Paolo Perna, MD; Elisa Bacillo, PHD; Paola Salacone, MD; Monica Gallo, MD; Luigi Mattiello, MS; Mariella Trovati, MD; Ezio Gaia, MD
Diabetes Care August 2004, Vol.27, 2052-2054. doi:https://doi.org/10.2337/diacare.27.8.2052
Impairment of Coronary Circulation by Acute Hyperhomocysteinemia in Type 2 Diabetic Patients
Antonino Coppola, MD; Costantino Astarita, MD; Michele Oliviero, MD; Dario Fontana, MD; Giuseppe Picardi, MD; Katherine Esposito, MD; Raffaele Marfella, MD, PHD; Ludovico Coppola, MD; Dario Giugliano, MD, PHD
Diabetes Care August 2004, Vol.27, 2055-2056. doi:https://doi.org/10.2337/diacare.27.8.2055
Reviews/Commentaries/ADA Statements
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
Jesús Medina, PHD; Luis I. Fernández-Salazar, MD; Luisa García-Buey, MD; Ricardo Moreno-Otero, MD
Diabetes Care August 2004, Vol.27, 2057-2066. doi:https://doi.org/10.2337/diacare.27.8.2057
Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition
Samuel Klein, MD; Nancy F. Sheard, SCD, RD; Xavier Pi-Sunyer, MD, MPH; Anne Daly, MS, RD, BC-ADM, CDE; Judith Wylie-Rosett, EDD, RD; Karmeen Kulkarni, MS, RD, BC-ADM, CDE; Nathaniel G. Clark, MD, MS, RD
Diabetes Care August 2004, Vol.27, 2067-2073. doi:https://doi.org/10.2337/diacare.27.8.2067
Inpatient Diabetes Control: Rationale
Diabetes Care August 2004, Vol.27, 2074-2080. doi:https://doi.org/10.2337/diacare.27.8.2074
Editorial
Diastolic Function and Type 1 Diabetes
Diabetes Care August 2004, Vol.27, 2081-2083. doi:https://doi.org/10.2337/diacare.27.8.2081
Letters: Observations
Poor Correlation of Pulse-Wave Velocity and Intima-Media Thickness in Diabetic Subjects
Diabetes Care August 2004, Vol.27, 2084. doi:https://doi.org/10.2337/diacare.27.8.2084
The Human Insulin Analog Aspart Can Induce Insulin Allergy
Diabetes Care August 2004, Vol.27, 2084-2085. doi:https://doi.org/10.2337/diacare.27.8.2084-a
Hypoadiponectinemia Is Closely Associated With Nonalcoholic Hepatic Steatosis in Obese Subjects
Diabetes Care August 2004, Vol.27, 2085-2086. doi:https://doi.org/10.2337/diacare.27.8.2085
Letters: Comments and Responses
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement
Diabetes Care August 2004, Vol.27, 2086-2087. doi:https://doi.org/10.2337/diacare.27.8.2086
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement
Diabetes Care August 2004, Vol.27, 2087-2088. doi:https://doi.org/10.2337/diacare.27.8.2087
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement
Diabetes Care August 2004, Vol.27, 2088. doi:https://doi.org/10.2337/diacare.27.8.2088
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement
Diabetes Care August 2004, Vol.27, 2088-2089. doi:https://doi.org/10.2337/diacare.27.8.2088-a
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to Holt, Citrome and Volevka, Isaac and Isaac, and Boehm et al.
Diabetes Care August 2004, Vol.27, 2089-2090. doi:https://doi.org/10.2337/diacare.27.8.2089
Randomized Trial Evaluating a Predominately Fetal Growth–Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Kitzmiller
Diabetes Care August 2004, Vol.27, 2091-2092. doi:https://doi.org/10.2337/diacare.27.8.2091
A Standardized Triglyceride and Carbohydrate Challenge: Response to Mohanlal and Holman
Diabetes Care August 2004, Vol.27, 2092-2093. doi:https://doi.org/10.2337/diacare.27.8.2092
A Standardized Triglyceride and Carbohydrate Challenge: Response to Thanopoulou, Karamanos, and Roussi
Diabetes Care August 2004, Vol.27, 2093. doi:https://doi.org/10.2337/diacare.27.8.2093
Role of Simvastatin as an Immunomodulator in Type 2 Diabetes: Response to Lopes-Virella et al.
Diabetes Care August 2004, Vol.27, 2093-2094. doi:https://doi.org/10.2337/diacare.27.8.2093-a
Improper Insulin Compliance May Lead to Hepatomegaly and Elevated Hepatic Enzymes in Type 1 Diabetic Patients: Response to Yu and Howard
Diabetes Care August 2004, Vol.27, 2094-2095. doi:https://doi.org/10.2337/diacare.27.8.2094
Peripheral Arterial Disease in People With Diabetes: Response to consensus statement
Diabetes Care August 2004, Vol.27, 2095. doi:https://doi.org/10.2337/diacare.27.8.2095
Peripheral Arterial Disease in People With Diabetes: Response to Hoyt
Diabetes Care August 2004, Vol.27, 2095. doi:https://doi.org/10.2337/diacare.27.8.2095-a
